1 Min Read
July 4 (Reuters) - Glenmark Pharmaceuticals Ltd
* Says receives MHRA, UK approval for Maloff protect, anti-malarial medication as a pharmacy license in UK Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.